Rallybio Corp Stock Analysis

Rallybio Stock Analysis Notes

About 76.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.62. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Rallybio Corp recorded a loss per share of 1.57. The entity had not issued any dividends in recent years. Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut. Rallybio Corporaton operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 45 people. To find out more about Rallybio Corp contact the company at 203 859 3820 or learn more at https://www.rallybio.com.

Rallybio Corp Investment Alerts

Rallybio Corp Upcoming and Recent Events

Rallybio Largest EPS Surprises

View All Earnings Estimates

Rallybio Stock Institutional Investors

Note, although Rallybio Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Rallybio Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 48.13 M.

Rallybio Profitablity

Management Efficiency

Rallybio Corp has return on total asset (ROA) of (0.3854) % which means that it has lost $0.3854 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6739) %, meaning that it created substantial loss on money invested by shareholders. Rallybio Corp's management efficiency ratios could be used to measure how well Rallybio Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of December 11, 2024, Return On Tangible Assets is expected to decline to -0.68. In addition to that, Return On Capital Employed is expected to decline to -0.78. At present, Rallybio Corp's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 204.5 M, whereas Return On Tangible Assets are forecasted to decline to (0.68).

Technical Drivers

As of the 11th of December 2024, Rallybio Corp holds the Coefficient Of Variation of 1970.51, semi deviation of 2.37, and Risk Adjusted Performance of 0.0441. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rallybio Corp, as well as the relationship between them.

Rallybio Corp Price Movement Analysis

Rallybio Corp Insider Trading Activities

Rallybio Corp Outstanding Bonds

Rallybio Corp Predictive Daily Indicators

Rallybio Corp Forecast Models

Rallybio Corp's time-series forecasting models are one of many Rallybio Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Rallybio Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Rallybio Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Rallybio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Rallybio Corp. By using and applying Rallybio Stock analysis, traders can create a robust methodology for identifying Rallybio entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Rallybio analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Rallybio analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Rallybio Corp stock analysis indicators help investors evaluate how Rallybio Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Rallybio Corp shares will generate the highest return on investment. By understating and applying Rallybio Corp stock analysis, traders can identify Rallybio Corp position entry and exit signals to maximize returns.

When running Rallybio Corp's price analysis, check to measure Rallybio Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rallybio Corp is operating at the current time. Most of Rallybio Corp's value examination focuses on studying past and present price action to predict the probability of Rallybio Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rallybio Corp's price. Additionally, you may evaluate how the addition of Rallybio Corp to your portfolios can decrease your overall portfolio volatility.